Seems BTG (the investment Co. has gone elsewhere leaving EPIC available for BTG (The Bio-Medico) to move their EPIC.

Whilst Historic graphs appear to have been retained, it seems MoneyAM can't move the Investor-comments section....?

. . . . DYOR . . .

BTG (medico) is the one with Varisolve (Varicose vein treatment) which took off spectacularly (Ho-Ho) nearly a year ago). They have several on-going medical products/treatm,ents which appear to be receiving milestones /income.

Yet, BTG trades on a big PE-ratio.

A couple of years ago they merged sweetly with Protherics (Snake anti-venom) which had an income but little new prospects . . . the joining suited most shareholders at the time.
. . . . but ignore anything I say.

paid 530 today growing self funding, bottom of chart, divi on the horizon, growing
upwards targets. directors good reputations , track records, ect the BB

Xmas 2015 very good Data to be realeased, 625p 19-11-15. ] much more 2016.
unable to confirm shire pharma director, at BTG ends BB

why would there be a further rns when their figures were released just a few days ago?
if it's just an additional or new director, that really isn't very exciting, whatever his cv

next numbers surely not due until mid may

Ah but the PE ratio is still over 60 DYOR and IC suggests they were misinformed ( " Cloudy" I read somewhere ), about the status of the Varisolve so there is still time and cost for the US insurance to accept they should be paying for this treatment.

It may also not help they are going to be seen as a British Company, when I suggest 4-years ago they should put in place plans to Mfr in the US.

I wasn't pleased to read LM had sold 25,000 shares ( DYOR ), and then been given ( TIN was it?), so she made a lot from previous investment -and then got a wad more.
Good on her, but it still leaves us with that PE ratio - and a relatively high-price for using Vs I understand, although that could be "negotiated" - resulting in less than projected profits...... Ah well, you can'y win 'em all...
There's not much time this year to recover (almost halving) the sp during 2015.
EDIT(14Nov2016)-1-year on and what's changed? Yawn...PE Ratio now 40...but no dividend, yet Co is awash with expensive Directors. ( BTW; Vs has been renamed ).
EDIT (11Dec2018)-Seems Americans Boston want to Buy has sent sp up to Yet PE is 210... meanwhile the business slumbers. Pity L-T UK Retail Investors won't see much benefit since the sp 823p is still not as high as from years ago.

sold today bad press telegraph boss arrested, S @ 616 will go back in, await news
target for buying unknown at this present moment BB

wrong on previouse, bb wrong BTG as i have sold , T to by 580 sorry BB